6533b7defe1ef96bd1275eec
RESEARCH PRODUCT
Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry
David R. WoodDavid R. WoodDavid R. WoodPedro Marques-vidalPedro Marques-vidalNebojsa LalicRenata CifkovaRenata CifkovaCatriona JenningsCatriona JenningsS. MancasCostas TsioufisCostas TsioufisJ. BadarieneSeppo LehtoAldo P. MaggioniS StoerkLinda MellbinLinda MellbinPeter U. HeuschmannPiotr JankowskiDusko VulicHosam Hasan-aliZeljko ReinerZeljko ReinerJan BruthansJan BruthansZlatko FrasZlatko FrasZlatko FrasVilnis DzerveVilnis DzerveJ CrowleyJ CrowleyGuy De BackerGuy De BackerDavor MilicicDavor MilicicMarina DolzhenkoNana PogosovaDragan LovicJohan De SutterJohan De SutterJaap W. DeckersJaap W. DeckersDirk De BacquerDirk De BacquerErkin M. MirrakhimovErkin M. MirrakhimovKairat DavletovKornelia KotsevaKornelia KotsevaLars RydénLars RydénDiederick E. GrobbeeDiederick E. GrobbeeAlmudena Castro CondeAna AbreuDan GaitaMirza DilicMirza DilicDelphine De SmedtDelphine De SmedtAndrejs ĒRglisAndrejs ErglisCarlos AguiarArno W. HoesArno W. HoesNina GotchevaRafael G. OganovLâle TokgözoğluLâle Tokgözoğlusubject
cardiovascular risk factorsMaleCardiac & Cardiovascular SystemsHeart diseaseEpidemiologymedicine.medical_treatmentHealth StatusEUROASPIRE ; cardiovascular risk factors ; guidelines ; lifestyle ; secondary preventionRisk Reduction Behavior*HSM CARRisk FactorsSecondary PreventionARTERY-DISEASEMyocardial infarctionEUROASPIREguidelinesDiet / adverse effectsRegistriesCardiovascular Diseases / physiopathology1102 Cardiorespiratory Medicine and HaematologyHydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*Smoking / epidemiologySmokingHealthy Lifestyle*Middle AgedPREVALENCEEuropeCardiovascular Diseases / diagnosisTreatment OutcomeCardiovascular DiseasesCardiovascular Agents / therapeutic use*LDL Cholesterol LipoproteinsFemaleEurope / epidemiologyCardiology and Cardiovascular MedicineLife Sciences & Biomedicinesecondary preventionmedicine.medical_specialtylifestyleSmoking / adverse effectsCardiovascular risk factorsHEART-DISEASERisk AssessmentLOW-INCOME COUNTRIESLife Style*Cardiovascular Diseases / prevention & control*Cardiovascular preventionmedicineJournal ArticleHumansHealthy Lifestyleddc:610Risk factorLife StyleAgedCardiovascular Diseases / epidemiologyScience & TechnologyTask forcebusiness.industryCardiovascular AgentsSMOKING-CESSATIONProtective Factorsmedicine.diseaseDietEUROASPIRE Investigators*Cross-Sectional StudiesMYOCARDIAL-INFARCTIONCLINICAL-PRACTICEFamily medicineHealth Care SurveysCardiovascular System & CardiologySmoking cessationPatient ComplianceHydroxymethylglutaryl-CoA Reductase InhibitorsSedentary BehaviorbusinessRisk Reduction BehaviorTASK-FORCEdescription
Aims The aim of this study was to determine whether the Joint European Societies guidelines on secondary cardiovascular prevention are followed in everyday practice. Design A cross-sectional ESC-EORP survey (EUROASPIRE V) at 131 centres in 81 regions in 27 countries. Methods Patients (<80 years old) with verified coronary artery events or interventions were interviewed and examined ≥6 months later. Results A total of 8261 patients (females 26%) were interviewed. Nineteen per cent smoked and 55% of them were persistent smokers, 38% were obese (body mass index ≥30 kg/m2), 59% were centrally obese (waist circumference: men ≥102 cm; women ≥88 cm) while 66% were physically active <30 min 5 times/week. Forty-two per cent had a blood pressure ≥140/90 mmHg (≥140/85 if diabetic), 71% had low-density lipoprotein cholesterol ≥1.8 mmol/L (≥70 mg/dL) and 29% reported having diabetes. Cardioprotective medication was: anti-platelets 93%, beta-blockers 81%, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers 75% and statins 80%. Conclusion A large majority of coronary patients have unhealthy lifestyles in terms of smoking, diet and sedentary behaviour, which adversely impacts major cardiovascular risk factors. A majority did not achieve their blood pressure, low-density lipoprotein cholesterol and glucose targets. Cardiovascular prevention requires modern preventive cardiology programmes delivered by interdisciplinary teams of healthcare professionals addressing all aspects of lifestyle and risk factor management, in order to reduce the risk of recurrent cardiovascular events.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2019-05-01 |